Researchers at Dana-Farber Cancer Institute showed that enumeration of circulating tumor cells (CTCs) with Menarini Silicon Biosystems’ CELLSEARCH® System and the CELLSERCH® Circulating Multiple ...
ESR1 mutations are present in up to 40% of ER+, HER2- advanced or metastatic breast cancers. ESR1 mutations are a known driver of resistance to standard endocrine therapy, and so far, have been ...
CO2 laser skin resurfacing machine is not a kind of laser, but a working mode of the laser. As long as the diameter of the laser beam is less than 500μm, and the laser beam is regularly arranged in a lattice, the laser working ...
TEL AVIV & WENDELSHEIM, Germany--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and MODAG GmbH today announced a strategic collaboration on the exclusive worldwide licensing and development of MODAG's lead ...
With the development of science and technology, plastic surgery technology is more and more developed, and the problems on the face of human beings can be solved by corresponding technology. With the increase of age, the appearance of ...
ViGeneron GmbH, a gene therapy company, announced the closing of its series A financing round led by WuXi AppTec and Sequoia Capital China. The proceeds will enable ViGeneron to accelerate its proprietary viral vector-based gene therapy ...
Efficient transfer of larger gene via ViGeneron’s proprietary technology platforms REVeRT and vgAAV ViGeneron advances its preclinical programs for Stargardt disease and Retinitis Pigmentosa into IND-enabling activities and ...
Presentation entitled “Accelerating drug development through improved gene-disease association using large-scale, real-world datasets” by Robert Lumsden, PhD, Director of Business Development at the 2021 Festival of Genomics ...
Uncovering associations between a disease and relevant genomic variants requires both detailed sequence data and detailed clinical data. Join Genuity Science Principal Scientist Anthony Ryan, PhD as he discusses the importance ...
The infrared coagulator, a spin off of laser technology, has been used for more than a decade, first in Europe and then in the United States, for the in-office elimination offlrst and second degree hemorrhoids. Even more recently, it has ...
Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for rare neurodegenerative and Alzheimer’s diseases, today announced that the U.S. Patent and Trademark Office (USPTO) ...
